Lab
Laboratorio Clinico Cayey, INC.
Laboratorio Clinico Cayey, INC. was paid $186K by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 17% of everything it billed.
33Billing provider infoLABORATORIO CLINICO CAYEY, INC.
CIDRA, PR 00739
CIDRA, PR 00739
33aNPI1386937464assigned 05/23/2011
33bProvider typeClinical Medical Laboratory
28Total paid$186K
24GClaims16,316
24DCodes billed25
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#460 of 777
Median peer was paid$278K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,812 | $13K | |
| 2019 | 1,704 | $10K | |
| 2020 | 1,479 | $13K | |
| 2021 | 3,302 | $49K | |
| 2022 | 2,721 | $41K | |
| 2023 | 2,556 | $32K | |
| 2024incomplete | 2,742 | $29K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 17% | 1,800 | 1,628 | $31K |
| 80061 | Lipid panel | 16% | 2,086 | 1,854 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15% | 678 | 612 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 3,115 | 2,706 | $21K |
| 80053 | Comprehensive metabolic panel | 11% | 1,857 | 1,708 | $20K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.6% | 669 | 601 | $16K |
| 81000 | 4.0% | 2,149 | 1,860 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.3% | 229 | 220 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 398 | 196 | $4K |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 1,631 | 1,353 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 321 | 277 | $3K |
| 86738 | 1.3% | 200 | 198 | $2K |
13 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 192 | $2K |
| 82274 | <1% | 121 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 69 | $1K |
| 82043 | <1% | 284 | $1K | |
| 86328 | <1% | 57 | $965.20 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 27 | $892.42 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 26 | $856.08 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 26 | $769.95 |
| 81001 | <1% | 242 | $681.00 | |
| 86696 | <1% | 25 | $452.22 | |
| 86695 | <1% | 25 | $306.58 | |
| 82570 | <1% | 61 | $274.94 | |
| 86592 | <1% | 28 | $115.79 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERALES SELLES, TANIA (GENERAL MANAGER)